Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions; Systemic Chronic Total Occlusion Revascularization Korea Research-Chronic Total Occlusion (STRIKE-CTO) Study

NCT03667196 is registered in ClinicalTrials.gov with Seung-Whan Lee, M.D., Ph.D. as lead sponsor.

NCT NCT03667196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions; Systemic Chronic Total Occlusion Revascularization Korea Research-Chronic Total Occlusion (STRIKE-CTO) Study
Lead sponsor
Seung-Whan Lee, M.D., Ph.D.
Phase
Observational
Overall status
Recruiting
Start date
January 11, 2018
Completion date
December 31, 2032
Enrollment
4,000 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

chronic total occlusion of coronary artery